Artificial intelligence (AI) has dominated Wall Street's investment arena in 2026, supported by substantial spending on data centers, advanced semiconductors, cloud computing and related infrastructure. Investors have focused on companies positioned to monetize AI adoption, while expectations of productivity gains and future revenue growth have helped sustain interest in the technology sector. However, elevated valuations, capital expenditure requirements and uncertainty over the pace of returns have also made diversification an important consideration.

As investors prepare for 2027, opportunities beyond AI deserve attention. Macroeconomic uncertainty, borrowing costs and changing consumer spending patterns could influence corporate earnings and equity valuations across industries. Against this backdrop, businesses serving essential needs may offer a different combination of demand visibility and long-term growth potential. Healthcare and waste management stand out because their underlying demand is linked to demographics, public health and routine commercial activity rather than the technology investment cycle alone.

Healthcare: Demographic Trends Support Long-Term Demand

Healthcare is supported by structural factors, including an aging population, ongoing medical needs and advances in diagnostics, medical devices and treatment. The Congressional Budget Office (CBO) projects that the U.S. population aged 65 and older will increase by approximately 15% from 2027 to 2036. It also expects federal spending on major healthcare programs to rise as enrollment and healthcare costs increase. These trends suggest a long-term demand foundation.

Investors can consider established companies such as Abbott Laboratories (ABT Quick QuoteABT - Free Report) , Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) and Stryker (SYK Quick QuoteSYK - Free Report) . Abbott offers exposure to medical devices, diagnostics and nutritional products, while Johnson & Johnson operates across pharmaceuticals and medical technology. Stryker provides medical and surgical equipment, including products used in hospital procedures. The companies’ diversified product portfolios and exposure to ongoing medical needs make them candidates for further research.

Nevertheless, healthcare is not immune to economic and policy risks. Pharmaceutical patent expirations, pricing pressures, regulatory changes, reimbursement constraints and research costs can affect profitability.

Waste Management: Essential Services Witness Recurring Demand

Waste management provides another way to diversify beyond AI. Residential communities, commercial establishments and industrial facilities require regular waste collection, processing and disposal. This creates a recurring demand base, while established operators may benefit from route density, long-term customer relationships, landfill assets and pricing power.

The need to maintain environmental services and modernize infrastructure also supports the industry's long-term relevance. For example, the U.S. Environmental Protection Agency estimates that wastewater and stormwater infrastructure will require at least $630 billion in investment over 20 years. Although this estimate concerns water infrastructure rather than waste collection directly, it indicates the broader scale of investment needs across essential environmental services.

Waste Management (WM Quick QuoteWM - Free Report) and Republic Services (RSG Quick QuoteRSG - Free Report) are two established companies currently in focus. Both provide waste collection and environmental services and serve commercial and residential customers. Their established service networks and recurring business activity offer potential advantages, although returns depend on execution, pricing, costs and valuation.